ERICA RAE MUCHA
Prescription History 1336856483
Nurse Practitioner - Family in Wasilla, AK
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ERICA RAE MUCHA, an active Family specialist practicing in Wasilla, AK. Our medical registry currently tracks 12 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 243 documented patient claims. Among these therapy options, the most frequently utilized medication is Levetiracetam, which accounts for 54 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other AK PrescribersVs. AK Avg |
|---|---|---|---|
| Levetiracetam | 54 | $76.71 | ▲ More than typical |
About Levetiracetam: Levetiracetam is used to treat seizures (epilepsy). Show more ▾ It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have. A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent. In 2024, this provider wrote 54 Medicare prescriptions for Levetiracetam, about 1.6 times the volume of the typical Alaska prescriber of this medication (33.6). Medicare paid an average of $76.71 per fill, versus $29.47 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average AK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 62 30-Day Fills standardized to 30-day supplies 1,551 Days of Medication total across all patients in 2024 | |||
| Carbidopa-LevodopaCarbidopa/Levodopa | 34 | $12.18▼ below AK avg | ≈ Typical |
About Carbidopa-Levodopa: This combination medication is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms (such as shakiness, stiffness, difficulty moving). Show more ▾ Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. Carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce some of levodopa's side effects such as nausea and vomiting. In 2024, this provider wrote 34 Medicare prescriptions for Carbidopa-Levodopa, about the same volume as the typical Alaska prescriber of this medication (35.2). Medicare paid an average of $12.18 per fill, versus $31.28 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average AK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AK average for this medication. 38.8 30-Day Fills standardized to 30-day supplies 1,156 Days of Medication total across all patients in 2024 | |||
| Donepezil Hcl | 27 | $5.96▼ below AK avg | ≈ Typical |
About Donepezil Hcl: Donepezil is used to treat confusion (dementia) related to Alzheimer's disease. Show more ▾ It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain. An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE. In 2024, this provider wrote 27 Medicare prescriptions for Donepezil Hcl, about 87% of the volume of the typical Alaska prescriber of this medication (31.1). Medicare paid an average of $5.96 per fill, versus $14.40 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average AK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AK average for this medication. 35 30-Day Fills standardized to 30-day supplies 800 Days of Medication total across all patients in 2024 | |||
| Nurtec OdtRimegepant Sulfate | 18 | $1,251.13▼ below AK avg | ≈ Typical |
About Nurtec Odt: This medication is used to prevent or treat migraine. Show more ▾ Rimegepant may work by changing the amount of a certain natural substance in the brain. It helps to relieve headache, pain, and other migraine symptoms (such as nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. In 2024, this provider wrote 18 Medicare prescriptions for Nurtec Odt, about 79% of the volume of the typical Alaska prescriber of this medication (22.9). Medicare paid an average of $1,251.13 per fill, versus $1,399.81 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average AK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AK average for this medication. 18.3 30-Day Fills standardized to 30-day supplies 483 Days of Medication total across all patients in 2024 | |||
| QuliptaAtogepant | 18 | $1,150.58▼ below AK avg | ≈ Typical |
About Qulipta: This medication is used to prevent migraines. Show more ▾ Atogepant may work by blocking the effects of a certain natural substance in the brain that causes migraines (calcitonin gene-related peptide - CGRP). In 2024, this provider wrote 18 Medicare prescriptions for Qulipta, about 87% of the volume of the typical Alaska prescriber of this medication (20.7). Medicare paid an average of $1,150.58 per fill, versus $1,264.30 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average AK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AK average for this medication. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 17 | $8.30▼ below AK avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 17 Medicare prescriptions for Gabapentin, about a third of the volume of the typical Alaska prescriber of this medication (54.4). Medicare paid an average of $8.30 per fill, versus $16.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AK average for this medication. 19 30-Day Fills standardized to 30-day supplies 570 Days of Medication total across all patients in 2024 | |||
| Lamotrigine | 16 | $7.37▼ below AK avg | ▼ Less than typical |
About Lamotrigine: Lamotrigine is used alone or with other medications to prevent and control seizures. Show more ▾ It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections). A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER. In 2024, this provider wrote 16 Medicare prescriptions for Lamotrigine, about a third of the volume of the typical Alaska prescriber of this medication (41.9). Medicare paid an average of $7.37 per fill, versus $13.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AK average for this medication. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2024 | |||
| UbrelvyUbrogepant | 15 | $1,104.26▼ below AK avg | ≈ Typical |
About Ubrelvy: This medication is used to treat migraine. Show more ▾ Ubrogepant may work by changing the amount of a certain natural substance in the brain. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. This medication is not used to prevent future migraines or lessen how often you get migraines. A calcitonin gene-related peptide receptor antagonist (CGRP-RA), for the acute treatment of migraine. In 2024, this provider wrote 15 Medicare prescriptions for Ubrelvy, about 77% of the volume of the typical Alaska prescriber of this medication (19.4). Medicare paid an average of $1,104.26 per fill, versus $1,241.14 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average AK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AK average for this medication. 15 30-Day Fills standardized to 30-day supplies 380 Days of Medication total across all patients in 2024 | |||
| Divalproex Sodium | 11 | $10.20▼ below AK avg | ▼ Less than typical |
About Divalproex Sodium: This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. Show more ▾ It works by restoring the balance of certain natural substances (neurotransmitters) in the brain. A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. In 2024, this provider wrote 11 Medicare prescriptions for Divalproex Sodium, about a third of the volume of the typical Alaska prescriber of this medication (33.4). Medicare paid an average of $10.20 per fill, versus $22.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AK average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
| Divalproex Sodium ErDivalproex Sodium | 11 | $14.44▼ below AK avg | ▼ Less than typical |
About Divalproex Sodium Er: This medication is used to treat seizure disorders, mental/mood conditions (such as manic phase of bipolar disorder), and to prevent migraine headaches. Show more ▾ It works by restoring the balance of certain natural substances (neurotransmitters) in the brain. A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. In 2024, this provider wrote 11 Medicare prescriptions for Divalproex Sodium Er, about a third of the volume of the typical Alaska prescriber of this medication (34.4). Medicare paid an average of $14.44 per fill, versus $37.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AK average for this medication. 11 30-Day Fills standardized to 30-day supplies 287 Days of Medication total across all patients in 2024 | |||
| Teriflunomide | 11 | $50.00 | – No State Data |
About Teriflunomide: This medication is used by adults to treat multiple sclerosis-MS. Show more ▾ It is not a cure for MS but is thought to work by decreasing certain immune system cells (lymphocytes) which can attack the nerves in your brain and spinal cord. This helps decrease the number of flare-ups (relapses) and may help slow down physical problems caused by MS. A leflunomide metabolite. In 2024, this provider wrote 11 Medicare prescriptions for Teriflunomide. Medicare paid an average of $50.00 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $50.00 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
| Topiramate | 11 | $9.00▼ below AK avg | ▼ Less than typical |
About Topiramate: Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). Show more ▾ This medication is also used to prevent migraine headaches and decrease how often you get them. Topiramate will not treat a migraine headache once it occurs. If you get a migraine headache, treat it as directed by your doctor (such as by taking pain medication, lying down in a dark room). Topiramate is known as an anticonvulsant or antiepileptic drug. A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss. In 2024, this provider wrote 11 Medicare prescriptions for Topiramate, about half the volume of the typical Alaska prescriber of this medication (24.1). Medicare paid an average of $9.00 per fill, versus $15.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AK average for this medication. 24 30-Day Fills standardized to 30-day supplies 700 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for ERICA RAE MUCHA is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Wasilla, AK practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among AK prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
